Development and Evaluation of mHealth Solutions to Monitor and Involve Cardiometabolic Patients in Self-care

Miguel Hernández University of Elche

Status: Unknown

Conditions: Hypertension; Asthma; Diabetes; Obesity; Copd; Heart Failure

Treatments: Device: Mobile application

Study type: Interventional

Funder types: Other

Identifiers

NCT04159558

18/324

Details and patient eligibility

About

To develop, using barcode systems and virtual pillbox (TuMedicina and Alice), an App aimed at patients and carers of patients with cardiometabolic diseases as the main diagnosis, over 45 years of age, who have one or more pathologies and use one or more drugs on a daily basis and to analyze their effectiveness in terms of achieving therapeutic objectives, self-efficacy and self-efficacy in self-care or provision of care (as the case may be), healthy behavior, therapeutic compliance and safe use of medication.

Full description

In order to achieve the objective of this study, an experimental study will carry out on patients with cardiometabolic and respiratory diseases and their caregivers. A participation of 100 patients and 85 caregivers is planned. The aim is for them to use the mobile application developed over three months in order to evaluate their health improvement comparing several clinical and analytic parameters before and after the use of the App, and also evaluating the satisfaction of the participants.

Enrollment: 100 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Cardio-metabolic disease, respiratory disease or neurologic disease

Exclusion criteria

Trial design

Primary purpose: Supportive Care

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

100 participants in 6 patient groups

experimental hypertension

Experimental group

Description:

The subjects with Hypertension will be trained in the use of the personalized help tool and will use it during a period of 3 months.

Treatment:

Device: Mobile application

experimental diabetes

Experimental group

Description:

The subjects with Diabetes will be trained in the use of the personalized help tool and will use it during a period of 3 months.

Treatment:

Device: Mobile application

experimental heart failure

Experimental group

Description:

The subjects with Heart failure will be trained in the use of the personalized help tool and will use it during a period of 3 months.

Treatment:

Device: Mobile application

experimental copd

Experimental group

Description:

The subjects with COPD will be trained in the use of the personalized help tool and will use it during a period of 3 months.

Treatment:

Device: Mobile application

experimental asthma

Experimental group

Description:

The subjects with Asthma will be trained in the use of the personalized help tool and will use it during a period of 3 months.

Treatment:

Device: Mobile application

experimental obesity

Experimental group

Description:

The subjects with Obesity will be trained in the use of the personalized help tool and will use it during a period of 3 months.

Treatment:

Device: Mobile application